Chinese medical exercises for metabolic syndrome and diabetes control

Completed

• Conditions: indicators of metabolic syndrome and diabetes control; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12607000528459
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-10-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Elevated blood glucose (> 5.6 mmol/L) but not currently taking diabetes medication and not being on diabetes medication in the three months prior to the program.

Exclusion Criteria

Medical condition which contraindicates participation in physical activity as suggested by the American College of Sports Medicine 2000; unwilling or unable to attend three sessions/week for 6 or 12 consecutive weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in indicators of metabolic syndrome including body mass index (BMI), waist circumference, blood pressure, fasting blood glucose, triglycerides and high density lipoprotein-cholesterol (HDL-C)[Physical measurement conducted at baseline (after randominzation), 6 weeks, 12 weeks, 18 weeks and 24 weeks; haematological measurement conducted at baseline (after randomization), 12 weeks and 24 weeks.];Changes in other indicators of diabetes control including HbA1c, fasting insulin, 2 hour blood glucose, 2 hour blood insulin, total cholesterol, low density lipoprotein-cholesterol (LDL-C); and derived estimates from the blood glucose and insulin, including insulin resistance, metabolic clearance rate and beta cell function[Assessed at baseline (after randomization), 12 weeks and 24 weeks]

Secondary Outcome Measures

Name	Time	Method
Changes in psychological measures including stress, depression, self-efficacy for physical activity, social support for physical activity[Assessed at baseline (after randominzation), 6 weeks, 12 weeks, 18 weeks and 24 weeks];Changes in indicators of strength, general health and well-being including leg strength, diabetic symptoms, quality of life[Assessed at baseline (after randominzation), 6 weeks, 12 weeks, 18 weeks and 24 weeks];Changes in behaviour measures including physical activity[Assessed at baseline (after randominzation), 6 weeks, 12 weeks, 18 weeks and 24 weeks]